Assessing antibody decline after chemotherapy of early chronic Chagas disease patients

BACKGROUND: Chagas disease remains a significant public health problem in Latin America. There are only two chemotherapy drugs, nifurtimox and benznidazole, and both may have severe side effects. After complete chemotherapy of acute cases, seropositive diagnosis may revert to negative. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Niamh, Cardinal, M. Victoria, Bhattacharyya, Tapan, Enriquez, Gustavo F., Macchiaverna, Natalia P., Alvedro, Alejandra, Freilij, Héctor, Martinez de Salazar, Pablo, Molina, Israel, Mertens, Pascal, Gilleman, Quentin, Gürtler, Ricardo E., Miles, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527601/
https://www.ncbi.nlm.nih.gov/pubmed/34670602
http://dx.doi.org/10.1186/s13071-021-05040-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527601/
https://www.ncbi.nlm.nih.gov/pubmed/34670602
http://dx.doi.org/10.1186/s13071-021-05040-6

Ejemplares similares